Achievement of On‑Treatment Remission With Risankizumab in Patients With Moderate‑to‑Severe Psoriasis. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 2];9(6):s653. Available from: https://skin.dermsquared.com/skin/article/view/3791